(25/) I am not sure if Evofem's old Phase 3 trial was rejected by the FDA only because of its Russia data. From its Phase 1 study, 65% of treatment arm experienced a AE. https://t.co/8g5AYSzu24 https://t.co/wbxUmivLvK
#PLOS: Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Can... http://t.co/wWJWbxDx
Phase I Study of Twice Daily Dosing of Acidform Vaginal Gel - Candidate Antimicrobial Contraceptive http://t.co/xma14WRu
#PLOSONE: Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel:... http://t.co/wWJWbxDx
Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contracep... http://t.co/qSl3PPVP
Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contracep... http://t.co/EOAYvHKo
Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contraceptive http://t.co/aOKS1HRk